Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 23, 2020

SELL
$40.22 - $62.0 $1,005 - $1,550
-25 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$57.95 - $66.61 $1,448 - $1,665
25 New
25 $1,000
Q3 2019

Nov 01, 2019

SELL
$60.08 - $88.17 $1,682 - $2,468
-28 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$81.3 - $97.35 $2,276 - $2,725
28 New
28 $2,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $130M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Harvest Group Wealth Management, LLC Portfolio

Follow Harvest Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.